MARATTO

review · Arab Journal of Urology

Oral desmopressin in nocturia with benign prostatic hyperplasia: A systematic review of the literature

201812 citationsOpen accessKafr el-Sheikh University

Abstract

Low-dose oral desmopressin therapy alone is an effective treatment for nocturia associated with LUTS in patients with BPH. Oral desmopressin combined with α-blockers is well tolerated and beneficial for improving the International Prostate Symptom Score and nocturnal symptoms. All patients should be educated about the mechanism of desmopressin action to avoid treatment discontinuation due to adverse events.

Research topics

  • Urinary Bladder and Prostate Research
  • Hormonal and reproductive studies
  • Pelvic floor disorders treatments

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.aju.2018.06.007

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.